Published in Cancer Weekly, September 24th, 2002
Endostatin is a natural inhibitor of angiogenesis, or neovascularization. Medical investigators from China, in conjunction with colleagues at the University of Pittsburgh School of Medicine in Pennsylvania, have determined recombinant or retroviral-mediated delivery of endostatin limits the proliferation of thyroid cancers implanted into nude mice.
Initially, Caisheng Ye and colleagues treated FTC-implanted mice with recombinant protein.
"Our results demonstrated that...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.